Skip to main content

With 25.8% CAGR, Telemedicine Market Size worth USD 396.76 Billion in 2027

Telemedicine Market Covered By Key Companies – American Well, MDLIVE Inc., Teladoc Health Inc., Doctor on Demand Inc., MeMD, Encounter Telehealth, Global Med, SnapMD

Pune, India, April 18, 2022 (GLOBE NEWSWIRE) — According to Fortune Business Insights, the telemedicine market is set to gain momentum from the introduction of artificial intelligence (AI)-powered booths in local malls. The system can dispense over 100 medications from a smart medicine cabinet. The report further states that the market size was USD 41.63 billion in 2019. It is projected to grow from USD 79.79 billion in 2020 to USD 396.76 billion in 2027 at a CAGR of 25.8% during 2020-2027.

Telemedicine is the term that denotes remote delivery of healthcare services, such as health consultations or assessments over the telecommunication infrastructures. The telemedicine concept allows healthcare providers to analyze, diagnose and treat patients using specialized technology, such as smartphones and video conferencing, without the requirement for an in-person visit.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/telemedicine-market-101067


Growth Factors-

An enhancing selection of the electronic medical record (EMR) and electronic healthcare record (EHR) or is a significant driver for market development. Furthermore, the increasing incidences of chronic diseases like diabetes & cancer and the inadequacy of efficient health services and good physicians in underdeveloped regions are boosting the demand of the telemedicine market.

The unexpected expense of executing telemedicine frameworks, i.e., EHR & EMR and need for telemedicine training proposed by strict government directions relating to telemedicine are considered to obstruct the telemedicine market development.

Telemedicine is a small segment of e-health and has been witnessing high growth over the past few years. It is estimated that in the coming years with advancements in technology this market will grow significantly.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/industry-reports/telemedicine-market-101067


Segment-

Services Segment to Dominate Stoked by Rising Adoption of Virtual Diagnostics Services

The Global Telemedicine Market is segmented on the basis of type, component, application, technology, delivery model, end-use and region & country level. Based on type the Telemedicine Market is bifurcated into Tele-hospital and Tele-home. In terms of component type, the market is classified as products and services. Based on application, the Global Telemedicine Market is segmented as Teleradiology, Telepathology, Telecardiology, Telepsychiatry, Teledermatology and Others.

Latest Update – Several governments have launched remote telehealth monitoring systems aimed at enhancing drug administration and illness management in the homecare context. The need for teleconsultation services will rise as a result.

Report Coverage Details
Forecast Period 2022-2027
Forecast Period 2020 to 2027 CAGR 25.8%
2027 Value Projection USD 396.76 billion
Base Year 2019
Market Size in 2020 USD 79.79 billion
Historical Data for 2018-2020
No. of Pages 147
Segments covered By Product, By Modality, By Type, By End-User, By Application, By Geography
Growth Drivers Telemedicine has showcased tremendous growth in recent years.
The increasing investment in virtual hospitals is set to augment the telemedicine market growth


Regional Insights-

North America – As per the assessment, North America is likely to lead the global market due to the presence of well-developed healthcare infrastructure. In 2019, North America generated USD 17.90 billion in terms of the telemedicine market share. This growth is attributable to the presence of several prominent players, such as MDLive and Teladoc in this region.

Europe – Europe is anticipated to acquire a second position in the global market for telemedicine owing to the adoption of new technologies in the health care sector. In Europe, the increasing usage of digital health owing to the implementation of favorable guidelines by government bodies would aid growth.

APAC – Because of the rapidly expanding patient pool and the increased acceptance of telehealth services to satisfy the need, APAC is expected to be the fastest-growing market. India, China, and Japan, among other growing countries, are likely to play a critical role in expanding the regional market.

Quick Buy –  Telemedicine Market:

https://www.fortunebusinessinsights.com/checkout-page/101067


Competitive Landscape-

Key Players Focus on Partnerships & Acquisitions to Broaden Their Product Lines

The global market for telemedicine houses numerous renowned companies that are mainly focusing on partnership and acquisition strategies. They are doing so to expand their product portfolios and to gain a large consumer base. Below are the two latest industry developments:

  • March 2020: VivaBem joined hands with Doktor.se to raise approximately USD 2.5 million. The fund will help them to refine its existing products by integrating the Doktor.se’s AI-driven technology. It will further improve the user experience for health and wellness services, chronic care management, and telemedicine.
  • January 2020: Teladoc Health acquired InTouch Health to deliver its product offerings to the latter’s clients in more than 450 hospitals. It will also help Teladoc to enhance patient experience in home care, ambulatory care, and acute care settings.

A list of all the renowned service providers operating in this market:

  • American Well (Boston, U.S.)
  • MDLIVE Inc. (Sunrise, U.S)
  • Teladoc Health Inc. (Purchase, U.S.)
  • Doctor on Demand Inc. (San Francisco, U.S.)
  • MeMD (Arizona, U.S.)
  • Encounter Telehealth (Nebraska, U.S.)
  • Global Med (Arizona, U.S.)
  • SnapMD (California, U.S.)
  • Other prominent players

Important facts-

  • Telehealth solutions have demonstrated the proficiency to strengthen health outcomes and reduce costs. Research suggests that telemedicine improves the health of diabetic patients, particularly in the case of older adults. 
  • Telehomecare is supposed to be one of the most profitable applications of telemedicine. The telehomecare market segment is anticipated to grow significantly in the near future. The rise in chronic disease incidences is a global concern that puts a burden on healthcare resources. Telehomecare is a resourceful way to provide care, monitor a patient, and deliver information, by using the advanced technology in telecommunication. Monitoring allows timely identification of disease, and thus, preventing severe chronic conditions.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/queries/telemedicine-market-101067


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.